Remdesivir manufacturer, Gilead, just set the price for the COVID-19 treatment: between $2,300 and $3,100 per patient. @icer_review estimates the treatment costs approx. $1 per vital to produce. $1.— Office of the State Treasurer (@PATreasurer) August 5, 2020
Innovation
Incentive
Risk taking
Synergy
Market forces
Scatter those words around in a paragraph of word salad and you have accurately recreated the experience